USE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT OF OBESITY: CLINICAL EVIDENCE AND NUTRITIONAL IMPLICATIONS. REMUNOM. 2025;21(05):1-11. doi:10.61164/dgpn4685